A Randomized, Open-Label, Phase II Study of Afatinib Versus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Tanguy Y. Seiwert, Jérôme Fayette, Didier Cupissol, J. M. Del-Campo, Paul M. Clément, J.M. Tourani, M. Degardin, Alice Blackman, Julie Cong, Flavio Solca,

Annals of Oncology · 2012 · 17 citations · 0 references

Concepts